Primary ovarian insufficiency has strong familiality: results of a multigenerational genealogical study.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
01 2023
Historique:
received: 23 05 2022
revised: 20 09 2022
accepted: 21 09 2022
pmc-release: 01 01 2024
pubmed: 26 10 2022
medline: 10 1 2023
entrez: 25 10 2022
Statut: ppublish

Résumé

To determine the familiality of primary ovarian insufficiency (POI) at population level through examination of multigenerational genealogical information linked to electronic medical records. Case-control study. Not applicable. Women with POI were identified using International Classification of Disease 9 and 10 codes in electronic medical records (1995-2021) from 2 major health care systems in Utah and reviewed for accuracy. Cases were linked to genealogy information in the Utah Population Database (UPDB). All included POI cases (n = 396) were required to have genealogy information available for at least 3 generations of ancestors. The risk of POI in relatives was compared with population rates for POI matched by age, sex, and birthplace. Not applicable. Relative risk of POI in first-, second-, and third-degree relatives. We identified 396 validated cases of POI with an associated 2,132 first-degree relatives, 5,245 second-degree relatives, and 10,853 third-degree relatives. We found an increased risk of POI among the extended relatives of cases. Specifically, first-degree relatives demonstrated an 18-fold increased risk of POI compared with controls relative risk ([RR],18.52 95% confidence interval [CI], 10.12-31.07), second-degree relatives demonstrated a 4-fold increase (RR, 4.21; CI, 1.15-10.79), and third-degree relatives demonstrated a 2.7-fold increase (RR, 2.65; CI, 1.14-5.21]). This is the first population-based study to assess the familial clustering of POI. The data demonstrate excess familiality, familial clustering of POI in excess compared with matched population rates of disease, among first-, second-, and third-degree relatives. These findings support a genetic contribution to POI.

Identifiants

pubmed: 36283864
pii: S0015-0282(22)01444-3
doi: 10.1016/j.fertnstert.2022.09.027
pmc: PMC10024920
mid: NIHMS1879045
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

128-134

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD099487
Pays : United States
Organisme : NICHD NIH HHS
ID : R56 HD090159
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002538
Pays : United States

Informations de copyright

Copyright © 2022 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Références

Fertil Steril. 2007 Mar;87(3):456-65
pubmed: 17074338
J Clin Endocrinol Metab. 2013 Sep;98(9):E1534-9
pubmed: 23902945
N Engl J Med. 2009 Feb 5;360(6):606-14
pubmed: 19196677
Maturitas. 1994 Aug;19(2):83-92
pubmed: 7968648
Neurol Genet. 2018 Aug 01;4(4):e249
pubmed: 30109265
J Endocr Soc. 2019 Feb 19;4(2):bvz037
pubmed: 32099950
Hum Hered. 2008;65(4):209-20
pubmed: 18073491
Am J Obstet Gynecol. 2020 Jul;223(1):105.e1-105.e8
pubmed: 31954153
J Natl Cancer Inst. 1994 Nov 2;86(21):1618-26
pubmed: 7932826
Hum Reprod. 2022 May 3;37(5):1030-1036
pubmed: 35134918
Int Urogynecol J. 2013 Mar;24(3):413-8
pubmed: 22890278
Nature. 2021 Aug;596(7872):393-397
pubmed: 34349265
Hum Reprod. 1998 Jul;13(7):1796-800
pubmed: 9740426
J Clin Endocrinol Metab. 2022 Feb 17;107(3):685-714
pubmed: 34718612
Endocr Rev. 1997 Feb;18(1):107-34
pubmed: 9034788
Hum Reprod. 1999 Nov;14(11):2731-4
pubmed: 10548611

Auteurs

Lauren Verrilli (L)

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, Utah; Intermountain Healthcare, Murray, Utah.

Erica Johnstone (E)

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, Utah.

Corrine Welt (C)

Division of Endocrinology, Metabolism and Diabetes, University of Utah School of Medicine, Salt Lake City, Utah. Electronic address: cwelt@genetics.utah.edu.

Kristina Allen-Brady (K)

Division of Epidemiology, Department of Internal Medicine, Salt Lake City, Utah.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH